Sonova Holding

Global Aging And AI Tech Will Shape Hearing Care

AnalystHighTarget

Not Invested

Community Contributor

Published

08 Jun 25

AnalystHighTarget's Fair Value

CHF 337.70

35.6% undervalued

10 Sep

CHF 217.60

-31.4%

-0.8%

-31.4%

-0.8%

You can edit this narrative until Jun 8 9:30 PM. Then, changes will post as Updates.

Author's Valuation

CHF 337.735.6% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

CHF 337.7

35.6% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

5.36%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

4.65%

Calculation

CHF 947.76m

Earnings '28

24.09x

PE Ratio '28

CHF 22.83b

Market Cap '28

CHF 22.83b

Market Cap '28

59.64m

No. shares '28

CHF 382.81

Share Price '28

CHF 382.81 Share Price '28

Discounted to 2025 @ 4.64% p.a.

CHF 334.08

Fair Value '25